Pfizer (PFE) is a pharmaceuticals company in the Health Care sector. Listed on the NASDAQ, Pfizer is a component of the S&P 500 index. As of 2026-06-10, the stock is trading at $25.60.
Key Metrics & Risk
Based on 5-year historical data from Yahoo Finance (daily returns, annualized using 252 trading days).
| Metric | Value |
|---|---|
| Latest Price | $25.60 |
| Latest Date | 2026-06-10 |
| Expected Return (Annualized) | -0.67% |
| Risk / Std Dev (Annualized) | 25.48% |
| Sharpe Ratio (rf=4.5%) | -0.20 |
S&P 500 Context
- Sector: Health Care
- Sub-Industry: Pharmaceuticals
- Exchange: NASDAQ
- Index: S&P 500 Component
Risk/Return Profile
The stock shows an annualized expected return of -0.67% with an annualized volatility of 25.48%. The Sharpe ratio of -0.20 (assuming 4.5% risk-free rate) indicates negative risk-adjusted returns relative to the risk-free rate.
Modern Portfolio Theory Positioning
This stock is plotted on the S&P 500 Modern Portfolio Theory chart which visualizes the risk/return trade-off across all S&P 500 components. The chart uses Sharpe ratio as the color dimension, allowing quick identification of stocks with superior risk-adjusted performance.
Fundamentals
| Metric | Value |
|---|---|
| Market Cap | 145.91B |
| Enterprise Value | 197.86B |
| Trailing P/E | 19.54 |
| Forward P/E | 9.02 |
| Price to Book | 1.62 |
| Price to Sales | 2.3 |
| EV/Revenue | 3.12 |
| EV/EBITDA | 7.77 |
| Profitability | | | Profit Margin | 11.83% | | Operating Margin | 31.62% | | ROE | 8.31% | | ROA | 5.69% |
| Growth | | | Revenue Growth | 5.4% | | Earnings Growth | -10.1% |
| Dividend | | | Dividend Yield | 672.0% | | Payout Ratio | 131.3% | | 5Y Avg Yield | 505.0% |
| Financial Health | | | Total Revenue | 63.32B | | Total Debt | 64.73B | | Total Cash | 13.08B | | Free Cash Flow | 12.38B | | Operating Cash Flow | 11.98B |
| Price & Technical | | | 52W High | $28.75$ | | 52W Low | $23.11$ | | 50-Day Avg | $26.53$ | | 200-Day Avg | $25.85$ | | Beta | 0.29 | | Shares Outstanding | 5.7B | | Float Shares | 5.69B | | Insider Holdings | 0.1% | | Institutional Holdings | 69.37% | | Short Ratio | 4.57 | | Short % of Float | 2.85% |
| Analyst Targets | | | Target High | $36.0$ | | Target Low | $24.0$ | | Target Mean | $29.19$ | | Target Median | $28.0$ | | # of Analysts | 27 | | Recommendation | buy |
Disclaimer
This analysis is for educational purposes only and does not constitute financial advice. Past performance is not indicative of future results. Always conduct your own research or consult a qualified financial advisor before making investment decisions.